• yl23455永利官网

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR-TRC-12002644】External cephalic version for breech presentation: A randomised controlled trial of anaesthetic interventions

    基本信息
    登记号

    ChiCTR-TRC-12002644

    试验状态

    结束

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2012-11-04

    临床申请受理号

    /

    靶点

    /

    适应症

    Breech Presentation during Pregnancy

    试验通俗题目

    External cephalic version for breech presentation: A randomised controlled trial of anaesthetic interventions

    试验专业题目

    External cephalic version for breech presentation: A randomised controlled trial of anaesthetic interventions

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    联系人通讯地址
    临床试验信息
    试验目的

    Our objectives in this prospective randomised blinded control study are to compare the outcome and effects of using (A) intravenous analgesia or (B) spinal anaesthesia for primary and reattempts of ECV at term. Secondary objectives are comparisons of the effects on the fetus, mechanical forces used, pain and side effects during ECV. The conclusion will define the role of using IV analgesia and spinal anaesthesia for ECV, and establish guidelines that are not available in current literature.

    试验分类
    试验类型

    随机平行对照

    试验分期

    其它

    随机化

    Random Shuffled coded envelope

    盲法

    /

    试验项目经费来源

    Research Grants Council of Hong Kong

    试验范围

    /

    目标入组人数

    63

    实际入组人数

    /

    第一例入组时间

    2003-05-01

    试验终止时间

    2008-10-01

    是否属于一致性

    /

    入选标准

    All singleton pregnancies suitable to have ECV for breech presentation at or beyond 36 weeks of gestation will be assessed for eligibility for inclusion. 24;25;27;40 ECVs for transverse lie, unstable lie, or second twin will be excluded for the purpose of this study. Patients suitable for this study would be in good health (ASA 1-2), and those contraindicated to have spinal anaesthesia or IV analgesia will be excluded. Informed written consent will obtained from all patients, before commencement of study.;

    排除标准

    NA;

    研究者信息
    研究负责人姓名
    试验机构

    Research Grants Council of Hong Kong

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    /

    联系人通讯地址

    The Chinese University of Hong Kong的其他临床试验

    更多

    最新临床资讯

    yl23455永利官网企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品